D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Net Change in Cash Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Net Change in Cash
myr85.6m
CAGR 3-Years
N/A
CAGR 5-Years
35%
CAGR 10-Years
N/A
P
PeterLabs Holdings Bhd
KLSE:PLABS
Net Change in Cash
myr2.4m
CAGR 3-Years
-30%
CAGR 5-Years
-12%
CAGR 10-Years
9%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Net Change in Cash
-myr152.1m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
-31%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Net Change in Cash
myr18.6m
CAGR 3-Years
152%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Net Change in Cash
myr3.4m
CAGR 3-Years
-33%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
K
Kotra Industries Bhd
KLSE:KOTRA
Net Change in Cash
myr12.1m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Duopharma Biotech Bhd's Net Change in Cash?
Net Change in Cash
85.6m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Net Change in Cash amounts to 85.6m MYR.

What is Duopharma Biotech Bhd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
35%

Back to Top